Business Description
Odyssey Therapeutics Inc
NAICS : 541714
SIC : 2836
Description
Odyssey Therapeutics Inc is a clinical-stage biopharmaceutical company seeking to transform the standard of care for patients suffering from autoimmune and inflammatory diseases. The Company is developing medicines that are designed to precisely target disease pathology with an initial emphasis on the innate immune system. Its programs include OD-07656, a small molecule scaffolding inhibitor of receptor-interacting protein kinase 2, or RIPK2, a small molecule scaffolding inhibitor of interleukin-1 receptor-associated kinase 4, or IRAK4, and OD-00910, an agonistic protein therapeutic targeting tumor necrosis factor receptor 2, or TNFR2, built from camelid heavy chain variable regions, or VHH, domains.
Financial Strength
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 6.73 | |||||
Equity-to-Asset | -2.29 | |||||
Debt-to-Equity | -0.05 | |||||
Debt-to-EBITDA | -0.71 | |||||
Piotroski F-Score | N/A/9 | |||||
WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year EBITDA Growth Rate | -6.1 | |||||
3-Year EPS without NRI Growth Rate | -8.2 | |||||
3-Year FCF Growth Rate | -5 | |||||
3-Year Book Growth Rate | -50 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 67.12 | |||||
9-Day RSI | 63.59 | |||||
14-Day RSI | 61.8 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 8.33 | |||||
Quick Ratio | 8.33 | |||||
Cash Ratio | 7.91 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History |
|---|
Profitability Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
FCF Margin % | -1383.84 | |||||
OCF Margin % | -1378.86 | |||||
ROA % | -15.34 | |||||
ROIC % | -54.71 | |||||
ROC (Joel Greenblatt) % | -151.28 | |||||
ROCE % | -16.97 | |||||
Moat Score | 5 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
PS Ratio | 174.72 | |||||
EV-to-EBIT | -19.82 | |||||
EV-to-EBITDA | -20.44 | |||||
EV-to-Revenue | 254.28 | |||||
EV-to-FCF | -18.37 | |||||
Earnings Yield (Greenblatt) % | -5.05 | |||||
FCF Yield % | -4.54 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:ODTX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Odyssey Therapeutics Inc Executives
DetailsGF Valueâ„¢
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 2.976 | ||
| EPS (TTM) ($) | -0.811 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | - | ||
| 14-Day RSI | 61.8 | ||
| 14-Day ATR ($) | 1.265438 | ||
| 20-Day SMA ($) | 17.5835 | ||
| 12-1 Month Momentum % | - | ||
| 52-Week Range ($) | 15.35 - 20.3 | ||
| Shares Outstanding (Mil) | 48.03 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9999 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Odyssey Therapeutics Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Odyssey Therapeutics Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Odyssey Therapeutics Inc Frequently Asked Questions
What is Odyssey Therapeutics Inc(ODTX)'s stock price today?
The current price of ODTX is $18.87. The 52 week high of ODTX is $20.30 and 52 week low is $15.35.
When is next earnings date of Odyssey Therapeutics Inc(ODTX)?
The next earnings date of Odyssey Therapeutics Inc(ODTX) is .
Does Odyssey Therapeutics Inc(ODTX) pay dividends? If so, how much?
Odyssey Therapeutics Inc(ODTX) does not pay dividend.
Guru Commentaries on NAS:ODTX
No articles.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Articles on Odyssey Therapeutics Inc
No articles.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers